SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-013688
Filing Date
2020-03-30
Accepted
2020-03-27 17:32:47
Documents
5
Effectiveness Date
2020-03-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A reph-defa14a_20200505.htm DEFA14A 31839
2 GRAPHIC g0t4ta01wzuf000003.jpg GRAPHIC 22207
3 GRAPHIC g0t4ta01wzuf000002.jpg GRAPHIC 61191
4 GRAPHIC g0t4ta01wzuf000004.jpg GRAPHIC 10848
5 GRAPHIC g0t4ta01wzuf000001.jpg GRAPHIC 37506
  Complete submission text file 0001564590-20-013688.txt   214762
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36329 | Film No.: 20753114
SIC: 2834 Pharmaceutical Preparations